wortmannin / TumAuto Cancer Research Results

wortm, wortmannin: Click to Expand ⟱
Features:
Wortmannin is a naturally occurring compound that is known for its inhibitory effects on certain enzymes, particularly phosphatidylinositol 3-kinase (PI3K). It is a fungal metabolite that was first isolated from the fungus Penicillium wortmanni.
Widely used in research as a tool to study the PI3K signaling pathway.
-known as AKT inhibitor

Wortmannin is a potent, naturally derived compound best known for its role as an inhibitor of phosphoinositide 3-kinases (PI3Ks). Unlike vitamins such as vitamin D or vitamin K2, wortmannin is not used as a nutritional supplement or therapeutic agent in the typical clinical setting.

- In cell culture studies, wortmannin is commonly used at concentrations in the low nanomolar range (e.g., 10–100 nM) to inhibit PI3K activity.

- In animal models, the dosing regimen can vary widely depending on the species, route of administration, and study design. Typical experimental doses may range from 0.1 to 1.0 mg/kg, but these studies are primarily investigative and not directed toward therapeutic dosing in humans.
TumAuto, Tumor autophagy: Click to Expand ⟱
Source: HalifaxProj(activate)
Type:
Autophagy genes, including Atg3, Atg5, Atg6, Atg7, Atg10, Atg12, and Atg17.
Tumor autophagy refers to the process by which cancer cells degrade and recycle cellular components through autophagy, a cellular mechanism that helps maintain homeostasis and respond to stress. Autophagy can have dual roles in cancer, acting as both a tumor suppressor and a promoter, depending on the context.
Authophagy is the process used by cancer cells to “self-eat” to survive. Authophagy can be both good and bad. If authophagy is prolonged this will become a lethal process to cancer. On the other hand, for a short while (e.g. during chemotheraphy, radiotheraphy, etc.) authophagy is used by cancer cells to survive.
For example, Chloroquine is a blocker of autophagy and has been used in a lab setting to dramatically enhance tumor response to radiotherapy, chemotherapy.
Scientific Papers found: Click to Expand⟱
312- AgNPs,  wortm,    Inhibition of autophagy enhances the anticancer activity of silver nanoparticles
- vitro+vivo, Cerv, HeLa
APA↑, p62↓, PIK3CA↑, TumVol↓, TumAuto↑, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Core Metabolism/Glycolysis ⓘ

PIK3CA↑, 1,  

Autophagy & Lysosomes ⓘ

APA↑, 1,   p62↓, 1,   TumAuto↑, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,  

Functional Outcomes ⓘ

TumVol↓, 1,  
Total Targets: 6

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: TumAuto, Tumor autophagy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:202  Target#:321  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page